Searchable abstracts of presentations at key conferences in endocrinology

ea0095p35 | Diabetes 2 | BSPED2023

Use of sensor augmented pump therapy is safe and effective in patients with significant deprivation and high risk HBA1c

Soo Janet , McCabe Angeline , Smith Paula , Gardner Chris

Background: Advances in insulin pumps and continuous monitoring mean that, where indicated sensor augmented pump therapy (SAPT) can be prescribed for children under NHS care in England. National Paediatric Diabetes Audit (NPDA) data shows improved diabetes outcomes (in terms of HBA1c) in children managing their diabetes in this way. Use of this technology is significantly lower in children in the lower deprivation quintiles and in patients from non white ethni...

ea0025p150 | Diabetes, metabolism and cardiovascular | SFEBES2011

The prevalence of non alcoholic fatty liver disease in GH deficiency and the effect of GH replacement

Gardner Chris , Irwin Andrew , Joseph Francis , Wong Chris , Adams Val , Daousi Christina , Kemp Graham , Cuthbertson Daniel

Background: Non-alcoholic fatty liver disease (NAFLD) is reported to be more prevalent in patients with GH deficiency (GHD) than in the general population. Case control studies have not however been undertaken. Recognition of NAFLD is important due to its association with cardiovascular disease and chronic liver disease.Aims: To determine i) the prevalence of NAFLD in patients with severe GHD compared to age and BMI-matched controls, and, ii) the effect ...

ea0023oc1.1 | Oral Communications 1 | BSPED2009

Cholesterol and apolipoprotein levels in a cohort of girls with Turner syndrome, and the effect of GH therapy

Gardner Chris , Garden Anne , Didi Mohammed , Newland Paul , Banerjee Indi , Blair Jo

Introduction: Ischaemic heart disease occurs seven times more frequently in women with Turner syndrome (TS) than the normal population. Adult TS subjects have raised serum cholesterol (Ch). In our service we measure Ch, apolipoprotein A1 (APA) and B (APB) annually in TS patients aged >5 years as APB:APA in childhood is a strong predictor of cardiovascular risk in adult life. Little is known about lipid profiles or the effects of GH or oestrogen (E2) in childhood...

ea0023p6 | (1) | BSPED2009

Growth, Final Height and Endocrine Sequelae post Bone Marrow Transplantation in a UK population of patients with Hurler Syndrome (MPS 1H)

Gardner Chris , Robinson Nicola , Mercer Jean , Meadows Tim , Will Andrew , Wynn Robert , Wraith Ed , Clayton Peter

Introduction: Hurler Syndrome, (MPS1H) is an inborn error of metabolism which was previously fatal in childhood. Bone marrow transplantation (BMT) has transformed the prognosis for these children. First BMTs are preconditioned with chemotherapy, and we have therefore put in place surveillance for endocrine sequelae. We present for the first time data on final adult height in children with MPS 1H post BMT, as well as the endocrine complications seen in this cohort.<p class=...